US Broker Ratings

Integra LifeSciences Holdings C (IART) Stock Analysis: Insights Into Its 4.92% Potential Upside

Integra LifeSciences Holdings C (IART) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Princeton, New Jersey,..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 138% Potential Upside in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is drawing significant attention in the biotechnology sector, not only for its innovative approach to tackling diseases driven by dysregulated aldosterone..

Mesoblast Limited (MESO) Stock Analysis: Unveiling a 95% Potential Upside in the Biotech Sector

Mesoblast Limited (NASDAQ: MESO) is capturing the attention of investors with its promising regenerative medicine platform and a significant potential upside of 95.23%. Specializing in groundbreaking..

Aurinia Pharmaceuticals (AUPH) Stock Analysis: Navigating a 22.4% Revenue Growth Amidst a Competitive Biotech Landscape

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a key player in the biotechnology sector, continues to capture investor attention with its promising growth trajectory and innovative therapeutic solutions...

The Pennant Group, Inc. (PNTG) Stock Analysis: Unpacking a 39.94% Potential Upside

Investors with an eye on the healthcare sector might find The Pennant Group, Inc. (NASDAQ: PNTG) an intriguing prospect. Headquartered in Eagle, Idaho, Pennant operates within..

10x Genomics, Inc. (TXG) Stock Analysis: Assessing the 7.62% Potential Upside for Investors

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation within the healthcare sector, specifically in the health information services industry. Founded in 2012 and..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a Potential 37% Upside for Investors

Astrana Health Inc. (ASTH) is making waves in the healthcare sector with promising growth prospects and a solid market position. With a current market capitalization of..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 41.57% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine solutions. Operating primarily in the medical instruments and supplies..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unpacking the 34% Potential Upside in the Medical Device Sector

Investors with an eye on the healthcare sector, particularly the medical device industry, may find Establishment Labs Holdings Inc (NASDAQ: ESTA) a compelling prospect. Headquartered in..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Through Healthcare with a 8.06% Potential Upside

Azenta, Inc. (NASDAQ: AZTA) offers a compelling story for investors in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

NeoGenomics, Inc. (NEO) Stock Analysis: Decoding a 11.36% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the diagnostics and research industry, presents a compelling opportunity for investors looking to tap into the healthcare sector...

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Eyeing a 108.92% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, offers investors an intriguing opportunity with a potential upside of 108.92%, according to analysts’..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Investor Outlook and Growth Potential in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is capturing the attention of investors with its innovative approach to healthcare, particularly in the burgeoning field of biotechnology. With a..

Aveanna Healthcare Holdings Inc (AVAH) Investor Outlook: Navigating Growth in Home Care with a 16.8% Revenue Surge

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, offers a compelling narrative for investors focused on the medical care facilities industry. Headquartered..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A Promising 26.4% Upside Potential in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), with its headquarters in Cambridge, Massachusetts, is a notable player in the biotechnology segment of the healthcare sector. The company is..

Phreesia, Inc. (PHR) Stock Analysis: Navigating 45.7% Revenue Growth in the Health Information Services Sector

Phreesia, Inc. (NYSE: PHR) stands as a notable player in the healthcare sector, particularly within the health information services industry. Known for its integrated SaaS-based software..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 278.64% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its innovative approach to developing oral small molecule therapeutics aimed..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Its 6.38% Return on Equity and Market Prospects

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, focusing on the development and commercialization of treatments for central nervous system (CNS) diseases...

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 6.68% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a notable player in the healthcare sector, carving its niche within the drug manufacturing industry focusing on specialty and..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring the 8.74% Upside Potential Amidst Innovative Non-Opioid Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a compelling player in the healthcare sector, specializing in non-opioid pain management and regenerative health solutions. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds